Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oseltamivir treatment versus treatment plus prophylaxis for influenza outbreaks in aged-care facilities
ACTRN12606000278538Phase 4Recruiting
- Sponsor
- The University of Sydney
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of oseltamivir in influenza (2 arms), sponsored by The University of Sydney. Primary endpoint: Attack rate of influenza in staff and residents. Started Jun 2006; status: recruiting.
02
Drugs
oseltamivir
03
Conditions
influenza
Beyond the preview
Go deeper on ACTRN12606000278538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000278538.